|
|||||
|
|
The cost effectiveness of rapid-acting insulin aspart compared with human insulin in type 2 diabetes patients: an analysis from the Japanese third-party payer perspective |
|
| Authors: | Pollock R F Valentine W J Pilgaard T Nishimura H |
| Affiliation: | Ossian Health Economics and Communications GmbH, Basel, Switzerland. pollock@ossianconsulting.com |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |